Skip to content

Nano-Carriers in Biofilm-Associated Infections: Clinical Challenges, Regulatory Hurdles, and Translational Perspectives.

Sep 2026 · Recent Advances in Drug Delivery and Formulation · 0 citations
Medicine

TL;DR

Although considerable advancements have been made in treating biofilm infections through the use of nanocarriers, there are still several issues that need to be addressed before moving into clinical practice.

Abstract

Biofilms are structured communities of microorganisms encapsulated by an Extracellular Polymeric Substance (EPS) matrix, which plays a crucial role in recurrent and chronic infections caused by implanted medical devices. The natural resistance of biofilms to antimicrobials and the difficulty in diagnosing them pose a challenge in the fight against infections. The biofilm life cycle, consisting of attachment, maturation, and dispersion stages, further complicates this issue. Nanocarriers have increasingly been proposed to overcome the challenges posed by biofilms because of their small size, large surface area-to-volume ratio, and physicochemical properties. Due to the unique characteristics of nanocarriers, researchers have used them to facilitate antimicrobial delivery, enhance drug permeability into biofilms, and promote the effects of the administered drugs. Researchers have used various techniques such as quorum-sensing inhibition, EPS matrix breakdown, and targeted drug delivery to treat biofilm infections. Although considerable advancements have been made in treating biofilm infections through the use of nanocarriers, there are still several issues that need to be addressed before moving into clinical practice.

View source

Similar papers

Aug 2026

Nanomedicine for biofilm associated infections: opportunities, challenges, and clinical translation

Comparative studies suggest that combination approaches, including enzyme functionalized or stimuli responsive nanoparticles paired with antibiotics, may outperform single modality treatments by simultaneously disrupting the biofilm matrix and delivering active agents.

Husni Farah, Munthar Kadhim-Abosaoda, Hayjaa Mohaisen-Mousa et al. · 0 citations
Conference Open access Sep 2026

A Comprehensive Review of Antimicrobial Nanoformulations: Engineered to Combat Biofilm-Associated Infections

This review establishes a consolidated evidence base for the design of next-generation antimicrobial nanoformulations, highlights their potential to address biofilm-associated infections, and identifies key knowledge gaps and translation barriers that must be addressed to realize their therapeutic promise.

Praveen Kumar Annagowni, Renuka Gudepu, S. Dahariya et al. · 0 citations
Review Open access 2026

Nanoparticle-antibiotic synergy against bacterial biofilms: mechanisms, therapeutic potential, and future directions

Bacterial biofilms pose significant challenges in clinical and industrial settings because of their resistance up to 1000-fold higher than that of planktonic bacteria. This resistance arises from extracellular polymeric matrix, reduced metabolic activity, and horizontal gene transfer. The growing burden of biofilm-asso...

I. C. Oladipo, K. Oloyede, O. B. Ogunleke et al. · 0 citations
Review Open access Sep 2026

Nanozymes for periodontal biofilm-associated challenges: mechanisms, platforms, and translational perspectives

This narrative review synthesizes current evidence on nanozyme applications for overcoming biofilm-associated challenges in periodontitis, focusing on antibiofilm mechanisms, representative platforms, delivery strategies, and translational hurdles.

Yu-Jie Ji, Tian-Yu Huang, Qiu-Dong Xu et al. · 0 citations
Review Sep 2026

Nanogel-Enabled Transdermal Platforms for Targeted Management of Biofilm-Associated Chronic Infections

The problem of biofilm infections is of considerable clinical importance because of the presence of an EPS matrix, metabolic heterogeneity, and antimicrobial tolerance, leading to low penetration of antibiotics and contributing to the failure of therapy and the development of antimicrobial resistance. This review a...

Aruna Sharma, Ameya Sharma, Divya Dheer et al. · 0 citations
Review Open access Sep 2026

Biofilm-driven antimicrobial resistance: A review of molecular mechanisms, clinical implications, and therapeutic innovation.

This review provides an integrated overview of the molecular and genetic determinants governing biofilm development, including surface attachment, matrix biosynthesis, quorum-sensing networks, cyclic-di-GMP signaling, maturation, and dispersal.

T. Chakraborty, Madhuchhanda Chatterjee, Sayanika Das et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.